Utility of Gomori methenamine silver stains in bronchoalveolar lavage specimens. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Utility of Gomori methenamine silver stains in bronchoalveolar lavage specimens.

Mod Pathol. 1994 Jun;7(5):599-604. Unique Identifier : AIDSLINE MED/95023863
Raab SS; Cheville JC; Bottles K; Cohen MB; Department of Pathology, University of Iowa, Iowa City.


Abstract: Bronchoalveolar lavage (BAL) with Gomori methenamine silver (GMS) stain is commonly used to detect Pneumocystis carinii and fungal organisms as causes of infectious pulmonic disease in immunosuppressed patients. However, several reports have indicated that GMS stains are not any more sensitive than conventional cytologic stains in detecting Pneumocystis organisms in select patient populations, such as those with acquired immunodeficiency syndrome (AIDS). To examine the utility of GMS stains in our laboratory, we retrospectively reviewed 243 BALs from 188 patients. Sensitivity of the GMS stain for Pneumocystis and for fungi detection was 100%. Sensitivity for Pneumocystis and for fungi detection by Papanicolaou stain alone was 79% and 88%, respectively; by Diff-Quik stain alone it was 68% and 88%, respectively; and by combined Papanicolaou and Diff-Quik stains it was 79% and 100%, respectively. In four additional cases, fungi were detected by other methods (culture, biopsy) and not by BAL. The GMS stain result was correlated with a number of risk variables to determine which variables were associated with GMS positivity. Using stepwise logistic regression, Pneumocystis positivity by GMS stain correlated (P < 0.0001) only with the variable of history of AIDS or AIDS risk factors. Fungal organism positivity by GMS stain correlated (P = 0.02) only with the variable of history of BAL positivity for fungus. Cost savings analyses were performed, estimating the cost of the GMS stain at $45 (total cost of GMS in 243 BALs was $10,935).(ABSTRACT TRUNCATED AT 250 WORDS)
Keywords: Adolescence Adult Aged Aged, 80 and over Bronchoalveolar Lavage Fluid/*MICROBIOLOGY Child Child, Preschool Female Fungi/*ISOLATION & PURIF Human Infant Male *Methenamine/ECONOMICS Middle Age Pneumocystis carinii/*ISOLATION & PURIF Sensitivity and Specificity Staining/ECONOMICS/*METHODS Support, Non-U.S. Gov't JOURNAL ARTICLEKWDadolescenceadultagedaged,80andoverbronchoalveolarlavagefluid/KWDmicrobiologychildchild,preschoolfemalefungi/KWDisolation&purifhumaninfantmaleKWDmethenamine/economicsmiddleagepneumocystiscarinii/KWDisolation&purifsensitivityandspecificitystaining/economics/KWDmethodssupport,non-uKWDsKWDgov'tjournalarticle
950130
M9510028

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .